CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-08 | Bhatia Sangeeta N. Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,292 | 646 | ||
| 2024-08-07 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −2,280 | $476.75 | $1.1M | 23,259 |
| 2024-08-01 | SACHS BRUCE I Director | Exercise or conversion 10b5-1 | +5,295 | $125.71 | $666K | 45,295 |
| 2024-08-01 | SACHS BRUCE I Director | Sale 10b5-1 | −5,295 | $508.00 | $2.7M | 40,000 |
| 2024-08-01 | SACHS BRUCE I Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,295 | 0 | ||
| 2024-07-30 | Kewalramani Reshma CEO & President | Sale 10b5-1 | −15,202 | $505.00 | $7.7M | 90,970 |
| 2024-07-24 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −2,280 | $488.46 | $1.1M | 25,539 |
| 2024-07-22 | Kewalramani Reshma CEO & President | Sale 10b5-1 | −15,202 | $497.00 | $7.6M | 106,172 |
| 2024-07-15 | SACHS BRUCE I Director | Grant or award · Deferred Stock Units | +89.26 | $490.12 | $44K | 14,943.01 |
| 2024-07-10 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −2,280 | $487.34 | $1.1M | 27,819 |
| 2024-06-26 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −2,280 | $471.72 | $1.1M | 30,099 |
| 2024-06-12 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −2,280 | $478.00 | $1.1M | 32,379 |
| 2024-06-12 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Sale 10b5-1 | −7,288 | $478.00 | $3.5M | 15,972 |
| 2024-06-11 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Shares withheld for taxes 10b5-1 | −6,824 | $481.96 | $3.3M | 23,260 |
| 2024-06-05 | Sachdev Amit EVP Chief Patient & Ext Af Off | Gift | −4,600 | 0 | ||
| 2024-06-03 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −3,250 | $460.00 | $1.5M | 47,137 |
| 2024-06-03 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −2,175 | $460.00 | $1.0M | 49,098 |
| 2024-05-31 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −2,250 | $445.00 | $1.0M | 51,273 |
| 2024-05-30 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −2,350 | $439.11 | $1.0M | 53,523 |
| 2024-05-29 | Bozic Carmen EVP and CMO | Sale 10b5-1 | −2,280 | $445.56 | $1.0M | 34,659 |
Page 19 of 27 · 524 trades